Literature DB >> 7496772

Progressive myoclonic ataxia associated with coeliac disease. The myoclonus is of cortical origin, but the pathology is in the cerebellum.

K P Bhatia1, P Brown, R Gregory, G G Lennox, H Manji, P D Thompson, D W Ellison, C D Marsden.   

Abstract

We report four patients with a progressive myoclonic ataxic syndrome and associated coeliac disease. The onset of the neurological syndrome followed the gastrointestinal and other manifestations of coeliac disease while on a gluten-free diet, in the absence of overt features of malabsorption or nutritional deficiency. The condition progressed despite strict adherence to diet. The neurological syndrome was dominated by action and stimulus sensitive myoclonus of cortical origin with mild ataxia and infrequent seizures. Plasmapharesis and immunosuppressive treatment were tried in two patients but were not beneficial. Post-mortem examination of the brain in one case showed selective symmetrical atrophy of the cerebellar hemispheres with Purkinje cell loss and Bergmann astrocytosis, and with preservation of the cerebral hemispheres and brainstem. Coeliac disease should be considered in the differential diagnosis of all patients presenting with a progressive myoclonic ataxic syndrome.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7496772     DOI: 10.1093/brain/118.5.1087

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  29 in total

1.  Epilepsy in coeliac disease: not just a matter of calcifications.

Authors:  Laura Licchetta; Francesca Bisulli; Lidia Di Vito; Chiara La Morgia; Ilaria Naldi; Umberto Volta; Paolo Tinuper
Journal:  Neurol Sci       Date:  2011-06-01       Impact factor: 3.307

2.  Cerebellar and cortical hypometabolism in progressive stimulus-sensitive limb myoclonus in celiac disease.

Authors:  Stefano Mozzetta; Miryam Carecchio; Gianmarco Gazzola; Diego Cecchin; Annachiara Cagnin
Journal:  Neurol Sci       Date:  2021-04-23       Impact factor: 3.307

Review 3.  Genomics in acute lymphoblastic leukaemia: insights and treatment implications.

Authors:  Kathryn G Roberts; Charles G Mullighan
Journal:  Nat Rev Clin Oncol       Date:  2015-03-17       Impact factor: 66.675

4.  Progressive myoclonic epilepsies: definitive and still undetermined causes.

Authors:  Silvana Franceschetti; Roberto Michelucci; Laura Canafoglia; Pasquale Striano; Antonio Gambardella; Adriana Magaudda; Paolo Tinuper; Angela La Neve; Edoardo Ferlazzo; Giuseppe Gobbi; Anna Teresa Giallonardo; Giuseppe Capovilla; Elisa Visani; Ferruccio Panzica; Giuliano Avanzini; Carlo Alberto Tassinari; Amedeo Bianchi; Federico Zara
Journal:  Neurology       Date:  2014-01-02       Impact factor: 9.910

Review 5.  Neurologic and psychiatric manifestations of celiac disease and gluten sensitivity.

Authors:  Jessica R Jackson; William W Eaton; Nicola G Cascella; Alessio Fasano; Deanna L Kelly
Journal:  Psychiatr Q       Date:  2012-03

6.  Dietary treatment of gluten ataxia.

Authors:  M Hadjivassiliou; G A B Davies-Jones; D S Sanders; R A Grünewald
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-09       Impact factor: 10.154

Review 7.  Gluten ataxia.

Authors:  Marios Hadjivassiliou; David S Sanders; Nicola Woodroofe; Claire Williamson; Richard A Grünewald
Journal:  Cerebellum       Date:  2008       Impact factor: 3.847

8.  Idiopathic cerebellar ataxia associated with celiac disease: lack of distinctive neurological features.

Authors:  M T Pellecchia; R Scala; A Filla; G De Michele; C Ciacci; P Barone
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-01       Impact factor: 10.154

9.  Decreased cerebellar fiber density in cortical myoclonic tremor but not in essential tremor.

Authors:  Arthur W G Buijink; Matthan W A Caan; Marina A J Tijssen; Johannes M Hoogduin; Natasha M Maurits; Anne-Fleur van Rootselaar
Journal:  Cerebellum       Date:  2013-04       Impact factor: 3.847

Review 10.  Neurological complications of coeliac disease.

Authors:  D S N A Pengiran Tengah; A J Wills; G K T Holmes
Journal:  Postgrad Med J       Date:  2002-07       Impact factor: 2.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.